5mg Semaglutide Reconstitution: What You're Actually Being Asked to Decide

The decision: licensed pre-filled pen or unlicensed compounded vial?

The phrase "5mg semaglutide reconstitution" points to a world of compounded semaglutide sold in powder-and-solvent formats, often via unregulated online sellers. These preparations are not the same medicine as Wegovy. Wegovy's dosing pathway begins at 0.25mg and escalates through 0.5mg, 1.0mg, 1.7mg, and 2.4mg weekly, with the newer 7.2mg maintenance dose now also MHRA-approved. A "5mg" dose sits outside that licensed schedule entirely, the NHS patient-level guidance on semaglutide, published at NHS.uk, reflects the authorised strengths and does not describe any 5mg preparation. So before you work through a reconstitution guide, the more important question is whether 5mg semaglutide is the right product to be using at all.

Compounded peptide vials require you to measure a diluent, draw up the correct volume, mix carefully, calculate your dose per injection, and store correctly to maintain sterility. Each of those steps is a point where an error can occur. That is not a theoretical concern, it is why medicines regulators license products in fixed, tested, ready-to-use formats in the first place. If you want to read more about what the licensed Wegovy dose schedule actually involves, that context makes the comparison clearer.

None of this means the question is naive. Compounded semaglutide became common partly because Wegovy was in short supply and partly because some sellers positioned reconstituted vials as equivalent or cheaper. They are neither regulated nor equivalent.

What the reconstitution process involves, and why UK guidance steers away from it

For context, reconstituting a peptide typically means drawing bacteriostatic water or saline into a syringe, injecting it slowly into a vial of lyophilised (freeze-dried) powder, swirling gently until dissolved, and then drawing a precise volume for injection based on a concentration calculation. Getting the concentration right matters enormously. A preparation labelled as containing a certain number of milligrams per vial only delivers the intended dose if the reconstitution volume is exact, and if the starting powder is genuine and of pharmaceutical grade.

The MHRA has repeatedly warned about fake and unlicensed weight-loss injectables circulating online. In 2025, enforcement operations seized around 20 million doses of illegally traded weight-loss medicines (approximately £45m street value), and a site producing counterfeit tirzepatide pens was raided in Northampton. Compounded semaglutide vials bought without a valid prescription from a UK prescriber are part of the same risk landscape. You can report a suspect seller via the MHRA's Yellow Card scheme, and you can verify any pharmacy offering you a prescription medicine at the GPhC register.

If you are working through a reconstitution protocol for 5mg semaglutide because you already have a vial, the practical steps matter, but so does pausing to ask where that vial came from and whether a UK prescriber with access to your medical history actually authorised it.

How licensed Wegovy actually works, and why the pen format exists

Novo Nordisk designed Wegovy as a pre-filled, single-use pen precisely to remove the variability and error risk that reconstitution introduces. Each pen contains a fixed, pre-measured dose. There are no calculations. You dial nothing. You inject once a week, rotate the site between your abdomen, thigh, or upper arm, and the pen does the rest. Storage is in the fridge at 2–8°C, with a limited window at room temperature, the Wegovy patient information leaflet gives exact guidance on that window, and your prescriber or pharmacist is the right person to ask about your specific situation. Some people find a weekly Monday injection fits naturally around their routine; others anchor it to a different day, and that is fine provided the interval stays consistent. The point is that the regime is designed to be simple and reproducible, which compounded vials with manual reconstitution are not.

For patients already familiar with the broader landscape (perhaps considering how 10mg semaglutide reconstitution compares) the same reasoning applies at every dose point: licensed, fixed-format pens exist because variability is the enemy of both safety and effectiveness. If you are curious about how the full weight-loss treatment landscape fits together, that context can help frame the choice.

Making the decision with a prescriber, not a calculator

There are reconstitution calculators available online for exactly this kind of preparation, and they are useful tools within their context. But a calculator cannot assess your health history, your current medications, or whether semaglutide is clinically appropriate for you. A detailed reconstitution guide can explain the steps; it cannot tell you whether the vial in front of you contains what the label claims.

The one genuinely useful thing about arriving at this question is that it often means you are serious about finding an effective, sustainable treatment. That motivation is worth channelling toward a route that is both regulated and clinically supervised. A look at how Wegovy is priced through licensed UK providers is a reasonable next step, understanding what the legitimate market looks like helps you spot what falls outside it. For a broader picture of what treatment involves from a clinical standpoint, our clinical team page explains who reviews every consultation at nume.

If you have already started down a compounded route and have concerns, or if you want to understand whether licensed Wegovy suits your circumstances, speaking to a GPhC-registered prescriber is the right move. Speak to our prescribers through a free consultation, a real clinician reads your answers the same day, and the conversation costs nothing.